Immunicon Announces Election of Byron Hewett as President, COO

Immunicon announced that its board of directors has elected Byron Hewett as president and chief operating officer (COO) reporting to Chairman and Chief Executive Officer (CEO) Edward Erickson. Hewett previously served as the company's COO and general manager, cancer products. Hewett will be responsible for day-to-day management of the company's operations and work closely with the board and senior management team in strategic planning and execution of the company's business plan. Concurrently, Erickson has notified the board of his intention to step down as CEO on March 31, 2006.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=232395&categoryid=33%2C34)